Teva Pharmaceuticals lawsuit

Disclaimer: This article is informational only and does not constitute legal advice. Mass tort and class action eligibility, deadlines, and settlement procedures vary by jurisdiction and individual circumstances. For specific case evaluation, consult a qualified attorney licensed in your state. Any payout ranges mentioned reflect publicly disclosed settlement administrator data and do not guarantee individual outcomes. As of January 2026, the Paragard IUD litigation remains a focal point for thousands of American women who have experienced complications related to the fragmentation of this copper contraceptive device. For many, what was intended to be a long-term, non-hormonal birth control solution resulted in unexpected surgeries and long-term health concerns. The legal landscape surrounding these claims has evolved significantly, with multi-district litigation (MDL 2974) in the Northern District of Georgia serving as the primary venue for consolidating these product liability cases. The core of the Paragard IUD lawsuit involves allegations that the device’s plastic T-frame is prone to breaking or splintering during the removal process. When this occurs, fragments of the copper-wrapped plastic can remain lodged in the uterus, potentially migrating to other organs or requiring invasive surgical procedures like a hysteroscopy or even a hysterectomy to retrieve. As we move through 2026, the focus for many claimants has shifted toward the results of bellwether trials and the potential for a global settlement framework, though no such agreement has been finalized by the defendants, Teva Pharmaceuticals and CooperSurgical. The Current Status of MDL 2974 in 2026 The Paragard IUD litigation is organized as a Multi-District Litigation (MDL), specifically MDL 2974, overseen by Judge Leigh Martin May in the U.S. District Court for the Northern District of Georgia. According to U.S. District Courts (USDC) — JPML Multi-District Litigation data, the number of active cases has continued to grow as more women discover that their removal complications may be linked to a manufacturing or design defect. Unlike a class action, where a few representative plaintiffs represent a large group, an MDL allows individual lawsuits to remain separate while sharing discovery and pretrial proceedings to increase efficiency. In 2026, the litigation is in a critical phase characterized by the analysis of bellwether trial outcomes. These initial trials are designed to test the strengths and weaknesses of the legal arguments from both sides. The results of these trials often serve as a barometer for future settlement negotiations. If juries consistently find that the manufacturers failed to provide …